Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Silo Pharma (SILO) Income from Non-Controlling Interests (2022 - 2023)

Silo Pharma's Income from Non-Controlling Interests history spans 2 years, with the latest figure at $1.0 million for Q2 2023.

  • For Q2 2023, Income from Non-Controlling Interests changed N/A year-over-year to $1.0 million; the TTM value through Jun 2023 reached $4.6 million, changed N/A, while the annual FY2022 figure was $3.9 million, N/A changed from the prior year.
  • Income from Non-Controlling Interests for Q2 2023 was $1.0 million at Silo Pharma, up from $906396.0 in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $1.7 million in Q4 2022 and bottomed at $906396.0 in Q1 2023.